In July 2024, Fourier Intelligence officially rebranded to Fourier, marking a new chapter in its evolution from a rehabilitation robotics company into a broader, general-purpose robotics innovator. The rebranding reflects the company’s expanding scope and ambition across multiple sectors.

Following this change, the company now operates under two primary divisions:

• Fourier focuses on developing general-purpose and humanoid robotics, including the advanced GR-1 humanoid robot, with applications spanning assistive tasks, scientific research, and real-world human-robot collaboration.

• Fourier Rehab is the dedicated rehabilitation arm of the company, continuing its mission to improve clinical outcomes through robotic exoskeletons and rehabilitation devices. It builds on Fourier’s legacy in healthcare by delivering cutting-edge, patient-centered solutions to hospitals and clinics worldwide.

Related ExR Coverage: ExR’s 2017 WearRAcon17 interview with Fourier Intelligence is a useful historical background on the company’s early lower-limb exoskeleton program, its U.S. debut, and its early thinking around rehabilitation versus assistive exoskeleton use.